V4C-233

V4C-233 is an experimental therapeutic candidate being developed by V4CURE for the treatment of renal carcinoma. V4CURE specializes in a drug discovery platform known as toxinology, which involves identifying, characterizing, and optimizing bioactive molecules derived from animal venoms. The company typically develops synthetic versions of these venom-derived toxins, which can be peptides or small molecules, to target specific biological receptors or pathways. V4C-233 is currently in the discovery and early preclinical stages of development. While its specific molecular target and mechanism of action have not been publicly disclosed, it is part of a pipeline focused on leveraging the high specificity and potency of venom-derived molecules for therapeutic applications in oncology and other fields.